Retinal Degenerative Diseases: Mechanisms and Experimental Therapy
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cham
Springer International Publishing
2016
|
| Ausgabe: | 1st ed. 2016 |
| Schriftenreihe: | Advances in Experimental Medicine and Biology
854 |
| Schlagworte: | |
| Online-Zugang: | BTU01 HTW01 UBR01 Volltext Inhaltsverzeichnis Abstract |
| Beschreibung: | 1 Online-Ressource (LV, 824 p. 62 illus. in color) |
| ISBN: | 9783319171210 |
| ISSN: | 0065-2598 |
| DOI: | 10.1007/978-3-319-17121-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043546975 | ||
| 003 | DE-604 | ||
| 005 | 20200925 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160510s2016 |||| o||u| ||||||eng d | ||
| 020 | |a 9783319171210 |c Online |9 978-3-319-17121-0 | ||
| 024 | 7 | |a 10.1007/978-3-319-17121-0 |2 doi | |
| 035 | |a (ZDB-2-SBL)978-3-319-17121-0 | ||
| 035 | |a (OCoLC)929991713 | ||
| 035 | |a (DE-599)BVBBV043546975 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-634 |a DE-523 | ||
| 082 | 0 | |a 617.7 |2 23 | |
| 245 | 1 | 0 | |a Retinal Degenerative Diseases |b Mechanisms and Experimental Therapy |c edited by Catherine Bowes Rickman, Matthew M. LaVail, Robert E. Anderson, Christian Grimm, Joe Hollyfield, John Ash |
| 250 | |a 1st ed. 2016 | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2016 | |
| 300 | |a 1 Online-Ressource (LV, 824 p. 62 illus. in color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in Experimental Medicine and Biology |v 854 |x 0065-2598 | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Neurosciences | |
| 650 | 4 | |a Ophthalmology | |
| 650 | 4 | |a Medicine & Public Health | |
| 650 | 4 | |a Medizin | |
| 650 | 0 | 7 | |a Netzhautdegeneration |0 (DE-588)4171515-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 655 | 7 | |8 2\p |0 (DE-588)1071861417 |a Konferenzschrift |y 2012 |z Bad Gögging |2 gnd-content | |
| 689 | 0 | 0 | |a Netzhautdegeneration |0 (DE-588)4171515-9 |D s |
| 689 | 0 | |8 3\p |5 DE-604 | |
| 700 | 1 | |a Bowes Rickman, Catherine |e Sonstige |4 oth | |
| 700 | 1 | |a LaVail, Matthew M. |e Sonstige |4 oth | |
| 700 | 1 | |a Anderson, Robert E. |e Sonstige |4 oth | |
| 700 | 1 | |a Grimm, Christian |e Sonstige |4 oth | |
| 700 | 1 | |a Hollyfield, Joe |e Sonstige |4 oth | |
| 700 | 1 | |a Ash, John |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-3-319-17120-3 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-319-17121-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 856 | 4 | 2 | |m Springer Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Springer Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Abstract |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2016_Fremddaten | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028962338 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-3-319-17121-0 |l BTU01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-319-17121-0 |l HTW01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-3-319-17121-0 |l UBR01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176208377675776 |
|---|---|
| adam_text | RETINAL DEGENERATIVE DISEASES
/
: 2016
TABLE OF CONTENTS / INHALTSVERZEICHNIS
PART I AGE-RELATED MACULAR DEGENERATION (AMD)
APOLIPOPROTEIN E ISOFORMS AND AMD
ROLE OF CHEMOKINES IN SHAPING MACROPHAGE ACTIVITY IN AMD
BIOLOGY OF P62/SEQUESTOSOME-1 IN AGE-RELATED MACULAR DEGENERATION (AMD)
GENE STRUCTURE OF THE 10Q26 LOCUS: A CLUE TO CRACKING THE ARMS2/HTRA1
RIDDLE?
CONDITIONAL INDUCTION OF OXIDATIVE STRESS IN RPE: A MOUSE MODEL OF
PROGRESSIVE RETINAL DEGENERATION
THERAPEUTIC APPROACHES TO HISTONE REPROGRAMMING IN RETINAL DEGENERATION
A BRIEF DISCUSSION ON LIPID ACTIVATED NUCLEAR RECEPTORS AND THEIR
POTENTIAL ROLE IN REGULATING MICROGLIA IN AGE-RELATED MACULAR
DEGENERATION (AMD)
EXTRACELLULAR MATRIX ALTERATIONS AND DEPOSIT FORMATION IN AMD
THE NLRP3 INFLAMMASOME AND ITS ROLE IN AGE-RELATED MACULAR DEGENERATION
OXIDATIVE STRESS AND THE NRF2 ANTI-OXIDANT TRANSCRIPTION FACTOR IN
AGE-RELATED MACULAR DEGENERATION
AGING CHANGES IN RETINAL MICROGLIA AND THEIR RELEVANCE TO AGE-RELATED
RETINAL DISEASE
VEGF-A AND THE NLRP3 INFLAMMASOME IN AGE-RELATED MACULAR DEGENERATION
INTERRELATION BETWEEN OXIDATIVE STRESS AND COMPLEMENT ACTIVATION IN
MODELS OF AGE-RELATED MACULAR DEGENERATION
GENE-DIET INTERACTIONS IN AGE-RELATED MACULAR DEGENERATION
CHALLENGES IN THE DEVELOPMENT OF THERAPY FOR DRY AGE-RELATED MACULAR
DEGENERATION
NANOCERIA: A POTENTIAL THERAPEUTIC FOR DRY AMD
Β-AMYLOIDOPATHY IN THE PATHOGENESIS OF AGE-RELATED MACULAR DEGENERATION
IN CORRELATION WITH NEURODEGENERATIVE DISEASES
PART II MACULAR DYSTROPHIES/INHERITED MACULAR DEGENERATION
DIFFERENT MUTATIONS IN ELOVL4 AFFECT VERY LONG CHAIN FATTY ACID
BIOSYNTHESIS TO CAUSE VARIABLE NEUROLOGICAL DISORDERS IN HUMANS
MOUSE MODELS OF STARGARDT 3 DOMINANT MACULAR DEGENERATION
CURRENT PROGRESS IN DECIPHERING IMPORTANCE OF VLC-PUFA IN THE RETINA
MALATTIA LEVENTINESE/DOYNE HONEYCOMB RETINAL DYSTROPHY: SIMILARITIES TO
AGE-RELATED MACULAR DEGENERATION AND POTENTIAL THERAPIES
PART III INHERITED RETINAL DEGENERATIONS
HSP90 AS A POTENTIAL THERAPEUTIC TARGET IN RETINAL DISEASE
LEBER CONGENITAL AMAUROSIS: GENOTYPES AND RETINAL STRUCTURE PHENOTYPES
A CHEMICAL MUTAGENESIS SCREEN IDENTIFIES MOUSE MODELS WITH ERG DEFECTS
ABLATION OF CHOP TRANSIENTLY ENHANCES PHOTORECEPTOR SURVIVAL BUT DOES
NOT PREVENT RETINAL DEGENERATION IN TRANSGENIC MICE EXPRESSING HUMAN
P23H RHODOPSIN
IDENTIFICATION OF A NOVEL GENE ON 10Q22 CAUSING AUTOSOMAL DOMINANT
RETINITIS PIGMENTOSA (ADRP)
FAM161A AND TTC8 ARE DIFFERENTIALLY EXPRESSED IN NON-ALLELELIC EARLY
ONSET RETINAL DEGENERATION
MUTATIONS IN THE DYNEIN1 COMPLEX ARE PERMISSIBLE FOR BASAL BODY
MIGRATION IN PHOTORECEPTORS BUT ALTER RAB6 LOCALIZATION
RDS FUNCTIONAL DOMAINS AND DYSFUNCTION IN DISEASE
TULP1 MISSENSE MUTATIONS INDUCES THE ENDOPLASMIC RETICULUM UNFOLDED
PROTEIN RESPONSE STRESS COMPLEX (ER-UPR)
UNDERSTANDING CONE PHOTORECEPTOR CELL DEATH IN ACHROMATOPSIA
GERANYLGERANYLACETONE SUPPRESSES N-METHYL-N-NITROSOUREA-INDUCED
PHOTORECEPTOR CELL LOSS IN MICE
MY RETINA TRACKER™: AN ON-LINE INTERNATIONAL REGISTRY FOR PEOPLE
AFFECTED WITH INHERITED ORPHAN RETINAL DEGENERATIVE DISEASES AND THEIR
GENETIC RELATIVES – A NEW RESOURCE
A MINI-REVIEW: ANIMAL MODELS OF GUCY2D LEBER CONGENITAL AMAUROSIS (LCA1)
A COMPREHENSIVE REVIEW OF MUTATIONS IN THE MERTK PROTO-ONCOGENE
PART IV IN VIVO IMAGING AND OTHER DIAGNOSTIC ADVANCES
NEW DEVELOPMENTS IN MURINE IMAGING FOR ASSESSING PHOTORECEPTOR
DEGENERATION IN VIVO
RELIABILITY AND REPEATABILITY OF CONE DENSITY MEASUREMENTS IN PATIENTS
WITH CONGENITAL ACHROMATOPSIA
QUANTITATIVE AUTOFLUORESCENCE IN BEST VITELLIFORM MACULAR DYSTROPHY: RPE
LIPOFUSCIN IS NOT INCREASED IN NON-LESION AREAS OF RETINA
INTERPRETATION OF FLOOD-ILLUMINATED ADAPTIVE OPTICS IMAGES IN SUBJECTS
WITH RETINITIS PIGMENTOSA
INTRA-FAMILIAL SIMILARITY OF WIDE-FIELD FUNDUS AUTOFLUORESCENCE IN
INHERITED RETINAL DYSTROPHY
WIDE-FIELD FUNDUS AUTOFLUORESCENCE FOR RETINITIS PIGMENTOSA AND
CONE/CONE-ROD DYSTROPHY.-THE DEVELOPMENT OF A CAT MODEL OF RETINAL
DETACHMENT AND RE-ATTACHMENT
PART V MECHANISMS OF DEGENERATION
THE ROLE OF X-CHROMOSOME INACTIVATION IN RETINAL DEVELOPMENT AND DISEASE
A NON-CANONICAL ROLE FOR Β-SECRETASE IN THE RETINA
THE CONSEQUENCES OF HYPOMORPHIC RPE65 FOR ROD AND CONE PHOTORECEPTORS
THE RATE OF VITAMIN A DIMERIZATION IN LIPOFUSCINOGENESIS, FUNDUS
AUTOFLUORESCENCE, RETINAL SENESCENCE AND DEGENERATION
CAN VITAMIN A BE IMPROVED TO PREVENT BLINDNESS DUE TO AGE-RELATED
MACULAR DEGENERATION, STARGARDT DISEASE AND OTHER RETINAL DYSTROPHIES?
CLASS I PHOSPHOINOSITIDE 3-KINASE EXERTS A DIFFERENTIAL ROLE ON CELL
SURVIVAL AND CELL TRAFFICKING IN RETINA
CELL CYCLE PROTEINS AND RETINAL DEGENERATION: EVIDENCES OF NEW POTENTIAL
THERAPEUTIC TARGETS
NEURONAL NITRIC OXIDE SYNTHASE AS A TRIGGER OF THE
N-METHYL-N-NITROSOUREA-INDUCED PHOTORECEPTOR CELL DEATH
MOLECULAR PRINCIPLES FORDECODING HOMEOSTASIS DISRUPTIONS IN THE
RETINAL PIGMENT EPITHELIUM:SIGNIFICANCEOF LIPID MEDIATORS TO RETINAL
DEGENERATIVE DISEASES
AGING AND VISION
PART VI NEUROPROTECTION, SMALL MOLECULES & RELATED THERAPEUTIC
APPROACHES
THE POTENTIAL USE OF PGC-1Α AND PGC-1Β TO PROTECT THE RETINA BY
STIMULATING MITOCHONDRIAL REPAIR
RETINAL CAVEOLIN-1 MODULATES NEUROPROTECTIVE SIGNALING
PHOTORECEPTOR NEUROPROTECTION: REGULATION OF AKT ACTIVATION THROUGH
SERINE/THREONINE PHOSPHATASES, PHLPP AND PHLPPL
THE ROLE OF AMPK PATHWAY IN NEUROPROTECTION
TAUROURSODEOXYCHOLIC ACID PROTECTS RETINAL FUNCTION AND STRUCTURE IN RD1
NEAR-INFRARED PHOTOBIOMODULATION IN RETINAL INJURY AND DISEASE
EXERCISE AND CYCLIC LIGHT PRECONDITIONING PROTECT AGAINST LIGHT-INDUCED
RETINAL DEGENERATION AND EVOKE SIMILAR GENE EXPRESSION PATTERNS
SMALL MOLECULES THAT PROTECT MITOCHONDRIAL FUNCTION FROM METABOLIC
STRESS DECELERATE LOSS OF PHOTORECEPTOR CELLS IN MURINE RETINAL
DEGENERATION MODELS
HISTONE DEACETYLASE: THERAPEUTIC TARGETS IN RETINAL DEGENERATION
THERAPEUTIC APPROACH OF NANOTECHNOLOGY FOR OXIDATIVE STRESS INDUCED
OCULAR NEURODEGENERATIVE DISEASES
TRANSSCLERAL CONTROLLED DELIVERY OF GERANYLGERANYLACETON USING A
POLYMERIC DEVICE PROTECTS RAT RETINA AGAINST LIGHT INJURY
TARGETING THE PROTEOSTASIS NETWORK IN RHODOPSIN RETINITIS PIGMENTOSA
PART VII GENE THERAPY & ANTISENSE.-GENE THERAPY FOR MERTK-ASSOCIATED
RETINAL DEGENERATIONS
TAMOXIFEN-CONTAINING EYE DROPS SUCCESSFULLY TRIGGER CRE-MEDIATED
RECOMBINATION IN THE ENTIRE EYE
DISTINCT EXPRESSION PATTERNS OF AAV8 VECTORS WITH BROADLY ACTIVE
PROMOTERS FROM SUBRETINAL INJECTIONS OF NEONATAL MOUSE EYES AT TWO
DIFFERENT AGES
CHARACTERIZATION OF RIBOZYMES TARGETING A CONGENITAL
NIGHT BLINDNESS MUTATION IN RHODOPSIN
ANTISENSE OLIGONUCLEOTIDE THERAPY FOR INHERITED RETINAL DYSTROPHIES
FUNCTIONAL RESCUE OF RETINAL DEGENERATION-ASSOCIATED MUTANT RPE65
PROTEINS
EVALUATION OF OCULAR GENE THERAPY IN AN ITALIAN PATIENT AFFECTED BY
CONGENITAL LEBER AMAUROSIS TYPE 2 TREATED IN BOTH EYES
PART VIII STEM CELLS & CELL-BASED THERAPIES
REGENERATIVE MEDICINE: SOLUTION IN SIGHT
PERSONALIZED MEDICINE: CELL AND GENE THERAPY BASED ON PATIENT-SPECIFIC
IPSC-DERIVED RETINAL PIGMENT EPITHELIUM CELLS
HUMAN RETINAL PIGMENT EPITHELIUM STEM CELL (RPESC)
EMBRYONIC STEM CELL‐DERIVED MICROVESICLES: COULD THEY BE USED FOR
RETINAL REGENERATION?
INTRAVITREAL IMPLANTATION OF GENETICALLY MODIFIED AUTOLOGOUS BONE
MARROW-DERIVED STEM CELLS FOR TREATING RETINAL DISORDERS.-GLIOSIS CAN
IMPEDE INTEGRATION FOLLOWING PHOTORECEPTOR TRANSPLANTATION INTO THE
DISEASED RETINA
INTERKINETIC NUCLEAR MIGRATION IN THE REGENERATING RETINA
PART IX PHOTORECEPTORS & INNER RETINA
USE OF A MACHINE LEARNING-BASED HIGH CONTENT ANALYSIS APPROACH TO
IDENTIFY PHOTORECEPTOR NEURITE PROMOTING MOLECULES
A NOVEL APPROACH TO IDENTIFY PHOTORECEPTOR COMPARTMENT-SPECIFIC TULP1
BINDING PARTNERS
THYROID HORMONE SIGNALING AND CONE PHOTORECEPTOR VIABILITY
IN-DEPTH FUNCTIONAL DIAGNOSTICS OF MOUSE MODELS BY SINGLE-FLASH AND
FLICKER ELECTRORETINOGRAMS WITHOUT ADAPTING BACKGROUND ILLUMINATION
THE ROLE OF INTRAFLAGELLAR TRANSPORT IN THE PHOTORECEPTOR SENSORY CILIUM
REGULATION OF RETINAL DEVELOPMENT VIA THE EPIGENETIC MODIFICATION OF
HISTONE
THE POTENTIAL ROLE OF FLAVINS AND RETBINDIN IN RETINAL FUNCTION AND
HOMEOSTASIS
IDENTIFICATION OF TYROSINE O SULFATED PROTEINS IN COW RETINA AND THE
661W CELL LINE
THE FUNCTION OF ARF-LIKE PROTEINS ARL2 AND ARL3 IN
PHOTORECEPTORS.-CHARACTERIZATION OF ANTIBODIES TO IDENTIFY CELLULAR
EXPRESSION OF DOPAMINE
RECEPTOR 4
A POSSIBLE ROLE OF NEUROGLOBIN IN THE RETINA AFTER OPTIC NERVE INJURY: A
COMPARATIVE STUDY OF ZEBRAFISH AND MOUSE RETINA
JNK INHIBITION REDUCED RETINAL GANGLION CELL DEATH AFTER
ISCHEMIA/REPERFUSION IN VIVO AND AFTER HYPOXIA IN VITRO
CELL FATE OF MUELLER CELLS DURING PHOTORECEPTOR REGENERATION IN AN
MNU-INDUCED RETINAL DEGENERATION MODEL OF ZEBRAFISH
POLYMODAL SENSORY INTEGRATION IN RETINAL GANGLION CELLS
PIGMENT EPITHELIUM-DERIVED FACTOR, A PROTECTIVE FACTOR FOR
PHOTORECEPTORS IN VIVO
PART X RETINAL PIGMENT EPITHELIUM (RPE)
THE MTOR KINASE INHIBITOR INK128 BLUNTS MIGRATION OF CULTURED RETINAL
PIGMENT EPITHELIAL CELLS
LIVE IMAGING OF LYSOTRACKER-LABELLED PHAGOLYSOSOMES TRACKS DIURNAL
PHAGOCYTOSIS OF PHOTORECEPTOR OUTER SEGMENT FRAGMENTS IN RAT RPE TISSUE
EX VIVO
CRE RECOMBINASE: YOU CAN’T LIVE WITH IT, AND YOU CAN’T LIVE WITHOUT
IT
EFFICIENCY OF MEMBRANE PROTEIN EXPRESSION FOLLOWING INFECTION WITH
RECOMBINANT ADENOVIRUS OF POLARIZED NON-TRANSFORMED HUMAN RETINAL
PIGMENT EPITHELIAL CELLS
CONTRIBUTION OF ION CHANNELS IN CALCIUM SIGNALING REGULATING
PHAGOCYTOSIS: MAXIK, CAV1.3 AND BESTROPHIN-1
LYSOSOMAL TRAFFICKING REGULATOR (LYST)
LIVE-CELL IMAGING OF PHAGOSOME MOTILITY IN PRIMARY MOUSE RPE CELLS
RPE CELL AND SHEET PROPERTIES IN NORMAL AND DISEASED EYES
VALPROIC ACID INDUCED HUMAN RETINAL PIGMENT EPITHELIAL CELL DEATH AS
WELL AS ITS SURVIVAL AFT
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
RETINAL DEGENERATIVE DISEASES
/
: 2016
ABSTRACT / INHALTSTEXT
CONTAINS THE PROCEEDINGS OF THE XVI INTERNATIONAL SYMPOSIUM ON RETINAL
DEGENERATION (RD2014), HELD JULY 13-18, 2014 AT THE ASILOMAR CONFERENCE
CENTER IN PACIFIC GROVE, CALIFORNIA. A MAJORITY OF THOSE WHO SPOKE AND
PRESENTED POSTERS AT THE MEETING CONTRIBUTED TO THIS VOLUME. THE
SYMPOSIUM ADDRESSED THE BLINDING DISEASES OF INHERITED RETINAL
DEGENERATIONS, WHICH HAVE NO EFFECTIVE TREATMENTS, AND AGE-RELATED
MACULAR DEGENERATION, WHICH HAS NO CURES, DESPITE THE FACT THAT IT IS AN
EPIDEMIC AMONG THE ELDERLY, WITH 1 IN 3-4 AFFECTED BY THE AGE OF 75. THE
RD2014 SYMPOSIUM FOCUSED ON THE EXCITING NEW DEVELOPMENTS AIMED AT
UNDERSTANDING THESE DISEASES AND PROVIDING THERAPIES FOR THEM.THE VOLUME
PRESENTS REPRESENTATIVE STATE-OF-THE-ART RESEARCH IN ALMOST ALL AREAS OF
RETINAL DEGENERATIONS, RANGING FROM CYTOPATHOLOGIC, PHYSIOLOGIC,
DIAGNOSTIC AND CLINICAL ASPECTS; ANIMAL MODELS; MECHANISMS OF CELL
DEATH; MOLECULAR GENETICS; AND DEVELOPING POTENTIAL THERAPEUTIC MEASURES
SUCH AS GENE THERAPY AND NEUROPROTECTIVE AGENTS FOR POTENTIAL
PHARMACEUTICAL THERAPY; AND SEVERAL SIGHT RESTORATION APPROACHES,
INCLUDING OPTOGENETICS. WHILE ADVANCES IN THESE AREAS OF RETINAL
DEGENERATIONS ARE INCLUDED, SEVERAL NEW TOPICS EITHER WERE IN THEIR
INFANCY OR DID NOT EXIST AT THE TIME OF THE LAST RD SYMPOSIUM, RD2012.
THESE INCLUDE MANY NEW DEVELOPMENTS IN SIGHT RESTORATION USING
OPTOGENETICS, RETINAL OR RPE CELL TRANSPLANTATION, STEM CELL APPROACHES
AND VISUAL PROSTHETIC DEVICES.IN ADDITION, MAJOR ADVANCES ARE PRESENTED
IN OTHER BASIC MECHANISMS IN AGE-RELATED MACULAR DEGENERATION, SEVERAL
NEW ASPECTS OF GENE AND ANTIOXIDANT THERAPY, AND REVOLUTIONARY NEW
IMAGING AND FUNCTIONAL TESTING THAT WILL HAVE A HUGE IMPACT ON THE
DIAGNOSIS AND FOLLOWING THE COURSE OF RETINAL DEGENERATIONS, AS WELL AS
TO PROVIDE NEW QUANTITATIVE ENDPOINTS FOR CLINICAL TRIALS. THE RETINA IS
AN APPROACHABLE PART OF THE CENTRAL NERVOUS SYSTEM (CNS), AND THERE IS A
MAJOR INTEREST IN NEUROPROTECTIVE AND GENE THERAPY FOR CNS DISEASES AND
NEURODEGENERATIONS, IN GENERAL. IT SHOULD BE NOTED THAT WITH SUCCESSFUL
AND EXCITING INITIAL CLINICAL TRIALS IN NEUROPROTECTIVE AND GENE
THERAPY, INCLUDING THE RESTORATION OF SIGHT IN BLIND CHILDREN, THE
RETINAL DEGENERATION THERAPIES ARE LEADING THE WAY TOWARDS NEW
THERAPEUTIC MEASURES FOR NEURODEGENERATIONS OF THE CNS.MANY OF THE
SUCCESSES RECENTLY REPORTED IN THESE AREAS OF RETINAL DEGENERATION
SPRANG FROM COLLABORATIONS ESTABLISHED AT PREVIOUS RD SYMPOSIA, AND MANY
OF THOSE ARE REPORTED AT THE RD2014 MEETING AND INCLUDED IN THIS VOLUME
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV043546975 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)978-3-319-17121-0 (OCoLC)929991713 (DE-599)BVBBV043546975 |
| dewey-full | 617.7 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 617 - Surgery & related medical specialties |
| dewey-raw | 617.7 |
| dewey-search | 617.7 |
| dewey-sort | 3617.7 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-319-17121-0 |
| edition | 1st ed. 2016 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03173nmm a2200649zcb4500</leader><controlfield tag="001">BV043546975</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20200925 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160510s2016 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783319171210</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-319-17121-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-319-17121-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-3-319-17121-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)929991713</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043546975</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-634</subfield><subfield code="a">DE-523</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">617.7</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Retinal Degenerative Diseases</subfield><subfield code="b">Mechanisms and Experimental Therapy</subfield><subfield code="c">edited by Catherine Bowes Rickman, Matthew M. LaVail, Robert E. Anderson, Christian Grimm, Joe Hollyfield, John Ash</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer International Publishing</subfield><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (LV, 824 p. 62 illus. in color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in Experimental Medicine and Biology</subfield><subfield code="v">854</subfield><subfield code="x">0065-2598</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine & Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Netzhautdegeneration</subfield><subfield code="0">(DE-588)4171515-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2012</subfield><subfield code="z">Bad Gögging</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Netzhautdegeneration</subfield><subfield code="0">(DE-588)4171515-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bowes Rickman, Catherine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">LaVail, Matthew M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anderson, Robert E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grimm, Christian</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hollyfield, Joe</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ash, John</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-3-319-17120-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-319-17121-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Springer Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Abstract</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2016_Fremddaten</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028962338</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-17121-0</subfield><subfield code="l">BTU01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-17121-0</subfield><subfield code="l">HTW01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-17121-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift gnd-content 2\p (DE-588)1071861417 Konferenzschrift 2012 Bad Gögging gnd-content |
| genre_facet | Konferenzschrift Konferenzschrift 2012 Bad Gögging |
| id | DE-604.BV043546975 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:28:32Z |
| institution | BVB |
| isbn | 9783319171210 |
| issn | 0065-2598 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028962338 |
| oclc_num | 929991713 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-634 DE-523 |
| owner_facet | DE-355 DE-BY-UBR DE-634 DE-523 |
| physical | 1 Online-Ressource (LV, 824 p. 62 illus. in color) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2016_Fremddaten |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Springer International Publishing |
| record_format | marc |
| series2 | Advances in Experimental Medicine and Biology |
| spelling | Retinal Degenerative Diseases Mechanisms and Experimental Therapy edited by Catherine Bowes Rickman, Matthew M. LaVail, Robert E. Anderson, Christian Grimm, Joe Hollyfield, John Ash 1st ed. 2016 Cham Springer International Publishing 2016 1 Online-Ressource (LV, 824 p. 62 illus. in color) txt rdacontent c rdamedia cr rdacarrier Advances in Experimental Medicine and Biology 854 0065-2598 Medicine Immunology Neurosciences Ophthalmology Medicine & Public Health Medizin Netzhautdegeneration (DE-588)4171515-9 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift gnd-content 2\p (DE-588)1071861417 Konferenzschrift 2012 Bad Gögging gnd-content Netzhautdegeneration (DE-588)4171515-9 s 3\p DE-604 Bowes Rickman, Catherine Sonstige oth LaVail, Matthew M. Sonstige oth Anderson, Robert E. Sonstige oth Grimm, Christian Sonstige oth Hollyfield, Joe Sonstige oth Ash, John Sonstige oth Erscheint auch als Druckausgabe 978-3-319-17120-3 https://doi.org/10.1007/978-3-319-17121-0 Verlag URL des Erstveröffentlichers Volltext Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Springer Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Abstract 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Retinal Degenerative Diseases Mechanisms and Experimental Therapy Medicine Immunology Neurosciences Ophthalmology Medicine & Public Health Medizin Netzhautdegeneration (DE-588)4171515-9 gnd |
| subject_GND | (DE-588)4171515-9 (DE-588)1071861417 |
| title | Retinal Degenerative Diseases Mechanisms and Experimental Therapy |
| title_auth | Retinal Degenerative Diseases Mechanisms and Experimental Therapy |
| title_exact_search | Retinal Degenerative Diseases Mechanisms and Experimental Therapy |
| title_full | Retinal Degenerative Diseases Mechanisms and Experimental Therapy edited by Catherine Bowes Rickman, Matthew M. LaVail, Robert E. Anderson, Christian Grimm, Joe Hollyfield, John Ash |
| title_fullStr | Retinal Degenerative Diseases Mechanisms and Experimental Therapy edited by Catherine Bowes Rickman, Matthew M. LaVail, Robert E. Anderson, Christian Grimm, Joe Hollyfield, John Ash |
| title_full_unstemmed | Retinal Degenerative Diseases Mechanisms and Experimental Therapy edited by Catherine Bowes Rickman, Matthew M. LaVail, Robert E. Anderson, Christian Grimm, Joe Hollyfield, John Ash |
| title_short | Retinal Degenerative Diseases |
| title_sort | retinal degenerative diseases mechanisms and experimental therapy |
| title_sub | Mechanisms and Experimental Therapy |
| topic | Medicine Immunology Neurosciences Ophthalmology Medicine & Public Health Medizin Netzhautdegeneration (DE-588)4171515-9 gnd |
| topic_facet | Medicine Immunology Neurosciences Ophthalmology Medicine & Public Health Medizin Netzhautdegeneration Konferenzschrift Konferenzschrift 2012 Bad Gögging |
| url | https://doi.org/10.1007/978-3-319-17121-0 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=028962338&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT bowesrickmancatherine retinaldegenerativediseasesmechanismsandexperimentaltherapy AT lavailmatthewm retinaldegenerativediseasesmechanismsandexperimentaltherapy AT andersonroberte retinaldegenerativediseasesmechanismsandexperimentaltherapy AT grimmchristian retinaldegenerativediseasesmechanismsandexperimentaltherapy AT hollyfieldjoe retinaldegenerativediseasesmechanismsandexperimentaltherapy AT ashjohn retinaldegenerativediseasesmechanismsandexperimentaltherapy |